Drug Index



Mechanism :

Rasburicase is a recombinant urate-oxidase enzyme, which converts uric acid to allantoin.

Indication :

• Hyperuricemia associated with malignancy

Contraindications :

History of anaphylaxis or severe hypersensitivity to rasburicase or any component of the formulation; history of hemolytic reaction or methemoglobinemia associated with rasburicase; glucose-6-phosphatase dehydrogenase (G6PD) deficiency.

Dosing :

IV: 0.2 mg/kg once daily for up to 5 days.

Adverse Effect :

Peripheral edema, headache, anxiety, rash, hypophosphatemia, hypervolemia, nausea, vomiting, abdominal pain, hyperbilirubinemia, increased serum ALT, antibody development, sepsis, fever.

Interaction :

No known significant interactions.

03/14/2020 06:46:02 Rasburicase
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0